Regenity Biosciences is heading to NASS 2026, October 14-17 in San Antonio, TX at the Henry B. González Convention Center. Our team will be exploring how our biomaterial platforms and CDMO capabilities can accelerate your spine innovation.

You’ll find Bill Messer (VP Commercial Operations) and Scott Salvatoriello (Director of Sales) ready to discuss your next challenge — whether you’re developing regenerative spine implants, evaluating bioresorbable materials, or building a manufacturing partnership.

From concept to commercial scale, we’ve got you covered. Regenity supports every step of your spine device’s journey: material selection, process development, regulatory strategy, validation, and manufacturing scale-up — all designed to get you to market faster.

Why NASS? It’s where spine surgeons, device innovators, and OEMs converge to shape the future of spine care. If you’re advancing regenerative solutions, exploring bioresorbable technologies, or searching for a CDMO partner who understands spine, this is the place to connect.

Working on a next-generation bioresorbable implant? Evaluating collagen or synthetic polymer platforms? Searching for a CDMO partner who can move fast? Our team is ready to talk.